6 May 2021

Cenkos Securities plc

("Cenkos" or the "Company")

Board Changes

Further to the announcement released on 9 December 2020 relating to the retirement of Jim Durkin, Chief Executive Officer, at the forthcoming Annual General Meeting, and the appointment of Julian Morse as the new Chief Executive Officer, the Board is pleased to confirm that Julian's appointment has now received regulatory approval from the Financial Conduct Authority. Julian will be appointed to the position of Chief Executive Officer which will take place immediately following the Company's Annual General Meeting on 12 May 2021.

The Board is also pleased to announce that Jeremy Osler's appointment as an Executive Director of the Company, has also received regulatory approval from the Financial Conduct Authority. Jeremy will join the Board immediately following the Company's Annual General Meeting on 12 May 2021.

Commenting on the Board changes, Lisa Gordon Non-Executive Chairman said:

"On behalf of the Board I would like to pay tribute to Jim Durkin, who has been central to the creation and development of Cenkos over the past 16 years.  I have hugely enjoyed working with Jim over the last 12 months on the blueprint for Cenkos' ongoing success and we wish him well in his forthcoming retirement.

The appointment of Julian Morse as Chief Executive Officer and wider changes to the senior management team across the Firm, including the appointment of Jeremy Osler to the Board as Executive Director, creates a strong team to lead and take the business forward." 

For further information, please contact:

Cenkos Securities plc

Lisa Gordon, Non-Executive Chairman

Julian Morse, Executive Director                                                  Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser                                                    Tel: 0203 368 3552

The Nisse Consultancy - Public relations

Jason Nisse                                                                                       Tel: 07769 688618

Andrew Garfield                                                                              Tel: 07974 982337

Additional Information 

The only change to the information previously supplied on 9 December 2020 in respect of Jeremy Osler's appointment as required under Schedule 2(g) of the AIM Rules is that his current interest in the Company's share capital is now made up of:  

49,627 Ordinary shares held in an ordinary managed account.

93,470 Ordinary shares held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares held in the Company's Share Incentive Plan.

Option over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

Option over 40,000 Ordinary shares held under the Company's Share Option Plan. These options are at 73.50 pence, subject to a performance condition, and vest in April 2024.

A nil cost Option over 510,000 Ordinary shares held under the Company's Long Term Incentive Plan. These options are subject to a performance condition and vest equally in April 2024, 2025 and 2026.